CDT Equity Inc. (CDT) Company Profile - Business Overview, Management Team & Corporate Information - Stocknear

CDT Equity Inc.

NASDAQ: CDT · Real-Time Price · USD
1.18
-0.01 (-0.84%)
At close: Sep 05, 2025, 3:59 PM
1.20
1.69%
After-hours: Sep 05, 2025, 04:55 PM EDT

Company Description

CDT Equity, Inc. engages in facilitating the development and commercialization of clinical assets.

The company was founded by David Joszef Tapolczay and Freda C.

Lewis-Hall in October 2021 is headquartered in Naples, FL.

CDT Equity Inc.
CDT Equity Inc. logo
Country United States
IPO Date Mar 28, 2022
Industry Biotechnology
Sector Healthcare
Employees 6
CEO James Bligh

Contact Details

Address:
4581 Tamiami Trail North
Naples, Florida
United States
Website https://www.conduitpharma.com

Stock Details

Ticker Symbol CDT
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency USD
CIK Code 0000913142
CUSIP Number 20678X106
ISIN Number US20678X3044
Employer ID 36-3601505
SIC Code 3357

Key Executives

Name Position
Dr. Andrew Regan Founder, Chief Executive Officer & Director
James Bligh Interim Chief Financial Officer & Director
Dr. David Joszef Tapolczay Head of Strategy & Licensing
Dr. Joanne M. Holland Chief Scientific Officer

Latest SEC Filings

Date Type Title
Sep 04, 2025 4 Filing
Aug 27, 2025 8-K Current Report
Aug 26, 2025 4 Filing
Aug 26, 2025 4 Filing
Aug 26, 2025 4 Filing
Aug 21, 2025 4 Filing
Aug 18, 2025 SCHEDULE 13G/A [Amend] Filing
Aug 14, 2025 10-Q Quarterly Report
Aug 14, 2025 10-Q/A [Amend] Quarterly Report
Aug 14, 2025 8-K Current Report